August 10, 2020

Volume X, Number 223

William Boudreaux

Bill Boudreaux is an experienced pharmaceutical patent lawyer, bringing more than 20 years of experience from both in-house and private practice settings. Bill’s extensive in-house experience at major pharmaceutical companies gives him a unique perspective, allowing him to provide clients with practical, business-focused advice. He is known for his thoughtful, thorough approach and ability to anticipate client needs.

Bill represents a broad range of biotech and pharma clients ranging from Global Fortune 50 Companies to start-ups.  While at Eli Lilly and Pfizer, he was primary patent counsel for several late-stage and post-launch drug products, including four blockbuster drugs. He has extensive experience in global patent portfolio creation and management, pharmaceutical patent life-cycle planning and IP due diligence. Bill’s experience also includes freedom-to-operate studies, due diligence reviews, infringement/validity studies, and strategy and support for Hatch-Waxman litigation.

Articles in the National Law Review database by William Boudreaux

LATEST LEGAL NEWS & ANALYSIS

TRENDING LEGAL ANALYSIS